Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stomach Neoplasms × Panobinostat × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 6 Recurrence 4 Myelodysplastic Syndromes 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myeloid, Acute 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large B-Cell, Diffuse 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Hodgkin Disease 2 Hematologic Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Blast Crisis 2 Thrombocytosis 1 Stomach Neoplasms 1 Somatostatinoma 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sezary Syndrome 1 Rhabdoid Tumor 1

Interventions

Capecitabine 24 Oxaliplatin 19 pembrolizumab 16 Fluorouracil 16 Cisplatin 15 Trastuzumab 12 Docetaxel 12 Leucovorin 10 Irinotecan 8 S 1 (combination) 7 Paclitaxel 7 Epirubicin 6 tegafur-gimeracil-oteracil 4 Hyperthermic Intraperitoneal Chemotherapy 4 Cyclophosphamide 4 titanium silicide 3 aldesleukin 3 Surgical Procedures, Operative 3 Ramucirumab 3 Carboplatin 3 vistusertib 2 tislelizumab 2 spartalizumab 2 rilotumumab 2 fludarabine phosphate 2 fludarabine 2 X-Rays 2 Taxes 2 Specimen Handling 2 Platinum 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01528501 2013-05-01

HDAC

Technical University of Munich

Phase 2 Terminated

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡